315 related articles for article (PubMed ID: 32841307)
21. Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent.
Palmer ND; Musani SK; Yerges-Armstrong LM; Feitosa MF; Bielak LF; Hernaez R; Kahali B; Carr JJ; Harris TB; Jhun MA; Kardia SL; Langefeld CD; Mosley TH; Norris JM; Smith AV; Taylor HA; Wagenknecht LE; Liu J; Borecki IB; Peyser PA; Speliotes EK
Hepatology; 2013 Sep; 58(3):966-75. PubMed ID: 23564467
[TBL] [Abstract][Full Text] [Related]
22. PNPLA3 polymorphisms (rs738409) and non-alcoholic fatty liver disease risk and related phenotypes: a meta-analysis.
Zhang L; You W; Zhang H; Peng R; Zhu Q; Yao A; Li X; Zhou Y; Wang X; Pu L; Wu J
J Gastroenterol Hepatol; 2015 May; 30(5):821-9. PubMed ID: 25641744
[TBL] [Abstract][Full Text] [Related]
23. Effects of PNPLA3, TM6SF2 and SAMM50 on the development and severity of non-alcoholic fatty liver disease in children.
Lee KJ; Moon JS; Kim NY; Ko JS
Pediatr Obes; 2022 Feb; 17(2):e12852. PubMed ID: 34490745
[TBL] [Abstract][Full Text] [Related]
24. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits.
Speliotes EK; Yerges-Armstrong LM; Wu J; Hernaez R; Kim LJ; Palmer CD; Gudnason V; Eiriksdottir G; Garcia ME; Launer LJ; Nalls MA; Clark JM; Mitchell BD; Shuldiner AR; Butler JL; Tomas M; Hoffmann U; Hwang SJ; Massaro JM; O'Donnell CJ; Sahani DV; Salomaa V; Schadt EE; Schwartz SM; Siscovick DS; ; ; ; Voight BF; Carr JJ; Feitosa MF; Harris TB; Fox CS; Smith AV; Kao WH; Hirschhorn JN; Borecki IB;
PLoS Genet; 2011 Mar; 7(3):e1001324. PubMed ID: 21423719
[TBL] [Abstract][Full Text] [Related]
25. Analysis of genotyping for predicting liver injury marker, procollagen III in persons at risk of non-alcoholic fatty liver disease.
Grove JI; Thiagarajan P; Astbury S; Harris R; Delahooke T; Guha IN; Aithal GP
Liver Int; 2018 Oct; 38(10):1832-1838. PubMed ID: 29493856
[TBL] [Abstract][Full Text] [Related]
26. Association of Genetic Risk Score With NAFLD in An Ethnically Diverse Cohort.
Wang J; Conti DV; Bogumil D; Sheng X; Noureddin M; Wilkens LR; Le Marchand L; Rosen HR; Haiman CA; Setiawan VW
Hepatol Commun; 2021 Oct; 5(10):1689-1703. PubMed ID: 34558842
[TBL] [Abstract][Full Text] [Related]
27. Validation of PNPLA3 polymorphisms as risk factor for NAFLD and liver fibrosis in an admixed population.
Mazo DF; Malta FM; Stefano JT; Salles APM; Gomes-Gouvea MS; Nastri ACS; Almeida JR; Pinho JRR; Carrilho FJ; Oliveira CP
Ann Hepatol; 2019; 18(3):466-471. PubMed ID: 31054980
[TBL] [Abstract][Full Text] [Related]
28. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network.
Namjou B; Lingren T; Huang Y; Parameswaran S; Cobb BL; Stanaway IB; Connolly JJ; Mentch FD; Benoit B; Niu X; Wei WQ; Carroll RJ; Pacheco JA; Harley ITW; Divanovic S; Carrell DS; Larson EB; Carey DJ; Verma S; Ritchie MD; Gharavi AG; Murphy S; Williams MS; Crosslin DR; Jarvik GP; Kullo IJ; Hakonarson H; Li R; ; Xanthakos SA; Harley JB
BMC Med; 2019 Jul; 17(1):135. PubMed ID: 31311600
[TBL] [Abstract][Full Text] [Related]
29. PNPLA3 I148M variant affects non-alcoholic fatty liver disease in liver transplant recipients.
Liu ZT; Chen TC; Lu XX; Cheng J; Xie HY; Zhou L; Zheng SS
World J Gastroenterol; 2015 Sep; 21(34):10054-6. PubMed ID: 26379412
[TBL] [Abstract][Full Text] [Related]
30. The common PNPLA3 variant p.I148M is associated with liver fat contents as quantified by controlled attenuation parameter (CAP).
Arslanow A; Stokes CS; Weber SN; Grünhage F; Lammert F; Krawczyk M
Liver Int; 2016 Mar; 36(3):418-26. PubMed ID: 26264356
[TBL] [Abstract][Full Text] [Related]
31. Genetic Polymorphisms of PNPLA3 and SAMM50 Are Associated with Nonalcoholic Fatty Liver Disease in a Korean Population.
Chung GE; Lee Y; Yim JY; Choe EK; Kwak MS; Yang JI; Park B; Lee JE; Kim JA; Kim JS
Gut Liver; 2018 May; 12(3):316-323. PubMed ID: 29271184
[TBL] [Abstract][Full Text] [Related]
32. GWAS-Identified Common Variants With Nonalcoholic Fatty Liver Disease in Chinese Children.
Shang XR; Song JY; Liu FH; Ma J; Wang HJ
J Pediatr Gastroenterol Nutr; 2015 May; 60(5):669-74. PubMed ID: 25522307
[TBL] [Abstract][Full Text] [Related]
33. Attenuated effect of PNPLA3 on hepatic fibrosis by HSD17B13 in Japanese patients with non-alcoholic fatty liver disease.
Seko Y; Yamaguchi K; Tochiki N; Yano K; Takahashi A; Okishio S; Kataoka S; Okuda K; Umemura A; Moriguchi M; Tanaka S; Mori K; Okanoue T; Itoh Y
Liver Int; 2020 Jul; 40(7):1686-1692. PubMed ID: 32342668
[TBL] [Abstract][Full Text] [Related]
34. The rs2294918 E434K variant modulates patatin-like phospholipase domain-containing 3 expression and liver damage.
Donati B; Motta BM; Pingitore P; Meroni M; Pietrelli A; Alisi A; Petta S; Xing C; Dongiovanni P; del Menico B; Rametta R; Mancina RM; Badiali S; Fracanzani AL; Craxì A; Fargion S; Nobili V; Romeo S; Valenti L
Hepatology; 2016 Mar; 63(3):787-98. PubMed ID: 26605757
[TBL] [Abstract][Full Text] [Related]
35. The HSD17B13 rs72613567 variant is associated with lower levels of albuminuria in patients with biopsy-proven nonalcoholic fatty liver disease.
Sun DQ; Wang TY; Zheng KI; Zhang HY; Wang XD; Targher G; Byrne CD; Chen YP; Yuan WJ; Jin Y; Zheng MH
Nutr Metab Cardiovasc Dis; 2021 Jun; 31(6):1822-1831. PubMed ID: 33853719
[TBL] [Abstract][Full Text] [Related]
36. Prevalence and severity of nonalcoholic fatty liver disease by transient elastography: Genetic and metabolic risk factors in a general population.
Petta S; Di Marco V; Pipitone RM; Grimaudo S; Buscemi C; Craxì A; Buscemi S
Liver Int; 2018 Nov; 38(11):2060-2068. PubMed ID: 29577560
[TBL] [Abstract][Full Text] [Related]
37. Additive effects of PNPLA3 and TM6SF2 on the histological severity of non-alcoholic fatty liver disease.
Koo BK; Joo SK; Kim D; Bae JM; Park JH; Kim JH; Kim W
J Gastroenterol Hepatol; 2018 Jun; 33(6):1277-1285. PubMed ID: 29193269
[TBL] [Abstract][Full Text] [Related]
38. Diagnosis of non-alcoholic fatty liver disease (NAFLD).
Yki-Järvinen H
Diabetologia; 2016 Jun; 59(6):1104-11. PubMed ID: 27091184
[TBL] [Abstract][Full Text] [Related]
39. Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci.
Stender S; Kozlitina J; Nordestgaard BG; Tybjærg-Hansen A; Hobbs HH; Cohen JC
Nat Genet; 2017 Jun; 49(6):842-847. PubMed ID: 28436986
[TBL] [Abstract][Full Text] [Related]
40. Interaction of TM6SF2 E167K and PNPLA3 I148M variants in NAFLD in northeast China.
Xu M; Li Y; Zhang S; Wang X; Shen J; Zhang S
Ann Hepatol; 2019; 18(3):456-460. PubMed ID: 31054977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
